Moderate alcohol consumption associated with decreased risk of heart failure
the ONA take:
According to a new study published online in the European Heart Journal, researchers have found that drinking up to seven alcoholic drinks per week in early to middle age is associated with 20% decreased risk for developing heart failure in men.
For the study, researchers from Brigham and Women's Hospital in Boston, Massachusetts, analyzed data from 14,629 people aged 45-64 years from the Atherosclerosis Risk in Communities Study conducted between 1987 and 1989. Participants were followed for 24-25 years until the end of 2011.
Researchers asked them about their alcohol consumption at the beginning of the study and at the three subsequent visits every 3 years years. During the follow-up period, 1,271 men and 1,237 women developed heart failure.
Results showed that those who drank up to seven drinks per week had the lowest rate of heart failure and those were considered former drinkers had the highest.
After adjusting for other factors, researchers found that men who drank up to seven drinks per week had a 20% decreased risk for developing heart failure compared with those who did not drink, and women who drank the same amount had a 16% reduced risk of heart failure. The findings suggest that moderate consumption of alcohol may provide protective benefits against heart failure.
Drinking up to seven alcoholic drinks per week is associated with 20% decreased risk for developing heart failure in men.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|